ly3437943 retatrutide triple agonist glp-1 gip glucagon How Does Work? The Mechanism Explained A review of an investigational
Description
As with any medication, its important to weigh the potential benefits against the risks and consider each persons individual situation
Platform Accuracy Note: Measured Health (Better Health Labs, Inc.) is a telehealth platform that facilitates access to consultations with licensed healthcare providers (through Measured-affiliated medical groups and/or Bridge, as applicable)
GLP-1 .131 , - GLP-1R .131 GLP-1R GLP-1 - .247 , .244 , - GLP-1R .248 GLP-1 - .248 - - .249,250 - GLP-1R GLP-1 .248,251,252 T2DM GLP-1 (: GLP-1RAs)
Recent phase two studies of retatrutide, a GLP-1/GIP/glucagon triple RA, showed a similar glucose-lowering effect, 14 but an even greater weight loss effect (24.2% at 48 weeks) than tirzepatide
Follow any specific instructions provided by the healthcare provider.
Ligand Bias and Pathway Integration Retatrutide is studied for its ability to engage multiple receptor pathways simultaneously
